Find the right fit for you - faster
Get tailored insights about working at Pharmacopeia in one quick step.
Pharmacopeia Snapshot
Pharmacopeia has searched its libraries and found some promising compounds. The biotech drug discovery firm has moved from sifting through and identifying small molecule compounds, to actually taking a handful into clinical trials. Its candidates include possible therapies for hypertension and renal diseases, a non-steroidal treatment for muscle wasting, a chemokin receptor antagonist that might be useful in treating inflammatory and autoimmune diseases, and a treatment for psoriasis. It has built up a pipeline with a mix of its own discoveries and other programs it has licensed from larger companies. Pharmacopeia was acquired by drug discovery firm Ligand Pharmaceuticals in late 2008.
